Nasdaq · CIK 0001370053
ANAB ANAPTYSBIO, INC
Insider trading from SEC Form 4. Last filing 10 d ago. Close $45.95 on Oct 9, 2026, +120% from the 52-week low and -34% from the high.
Last 90 days
Net insider value
-$249k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$249k by 1 insider
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
ANABOct 9, 2026 · close 45.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ANAPTYSBIO, INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 3Weak | Hollings Renton director sell | $249k 5,000 shares | -31% | +144% from low-30% from high | |
| 33Weak | Eric J Loumeau CHIEF LEGAL OFFICER sell | $510k 10,000 shares | -53% | +307% from low0% from high | |
| 40Moderate | Dennis Mulroy CHIEF FINANCIAL OFFICER sell | $500k 10,000 shares | -52% | +307% from low0% from high | |
| 3Weak | Paul F. Lizzul Chief Medical Officer sell | $75k 1,500 shares | -5% | +307% from low0% from high | |
| 52Moderate | J. Anthony Ware director sell | $193k 3,900 shares | -29% | +304% from low-1% from high | |
| 40Moderate | Eric J Loumeau CHIEF LEGAL OFFICER sell | $1.0M 22,641 shares | -105% | +264% from low-2% from high | |
| 43Moderate | Dennis Mulroy CHIEF FINANCIAL OFFICER sell | $705k 15,725 shares | -63% | +264% from low-2% from high | |
| 3Weak | Eric J Loumeau CHIEF LEGAL OFFICER sell | $239k 8,240 shares | -48% | +147% from low-13% from high | |
| 12Weak | Hollings Renton director sell | $201k 10,231 shares | -67% | +70% from low-48% from high | |
| 26Weak | Hollings Renton director sell | $493k 20,925 shares | -81% | +93% from low-41% from high | |
| 21Weak | Hollings Renton director sell | $72k 3,015 shares | -38% | +89% from low-42% from high | |
| 21Weak | Dennis M Fenton director sell | $72k 3,015 shares | -38% | +89% from low-42% from high | |
| 58Moderate | EcoR1 Capital, LLC director, owner buy | $1.1M 85,098 shares | +1% | +1% from low-67% from high | |
| 13Weak | Hollings Renton director sell | $250k 10,000 shares | -84% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Hollings Renton director | MOption exercise Common Stock10b5-1 | +5,000 | $18.03 | $90k | 15,995 | 10 d ago |
| Oct 1, 2026 | Hollings Renton director | SOpen-market sale Common Stock10b5-1 | -5,000 | $49.87 | $249k | 10,995 | 10 d ago |
| Oct 1, 2026 | Hollings Renton director | MOption exercise Common Stockderivative10b5-1 | -5,000 | $0.00 | $0 | 10,000 | 10 d ago |
| Sep 15, 2026 | John A Orwin director | MOption exercise Common Stock | +1,300 | $0.00 | $0 | 17,995 | 25 d ago |
| Sep 15, 2026 | John A Orwin director | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 0 | 25 d ago |
| Dec 22, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock10b5-1 | +10,000 | $14.02 | $140k | 18,947 | Dec 23, 2025 |
| Dec 23, 2025 | J. Anthony Ware director | SOpen-market sale Common Stock | -3,900 | $49.58 | $193k | 9,630 | Dec 23, 2025 |
| Dec 22, 2025 | Paul F. Lizzul Chief Medical Officer | MOption exercise Common Stock10b5-1 | +1,500 | $18.50 | $28k | 28,467 | Dec 23, 2025 |
| Dec 23, 2025 | John P. Schmid director | JOther Common Stockindirect: By ESOP | -11,068 | $51.00 | $564k | 0 | Dec 23, 2025 |
| Dec 22, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Common Stock10b5-1 | +10,000 | $20.16 | $202k | 19,401 | Dec 23, 2025 |
| Dec 22, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | SOpen-market sale Common Stock10b5-1 | -10,000 | $51.00 | $510k | 8,947 | Dec 23, 2025 |
| Dec 22, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -10,000 | $50.00 | $500k | 9,401 | Dec 23, 2025 |
| Dec 22, 2025 | Paul F. Lizzul Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -1,500 | $50.00 | $75k | 26,967 | Dec 23, 2025 |
| Dec 22, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 60,600 | Dec 23, 2025 |
| Dec 22, 2025 | Paul F. Lizzul Chief Medical Officer | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -1,500 | $0.00 | $0 | 83,500 | Dec 23, 2025 |
| Dec 22, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 43,000 | Dec 23, 2025 |
| Dec 16, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock10b5-1 | +5,000 | $14.02 | $70k | 14,088 | Dec 18, 2025 |
| Dec 16, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Common Stock10b5-1 | +10,000 | $20.16 | $202k | 25,126 | Dec 18, 2025 |
| Dec 16, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock10b5-1 | +7,500 | $20.16 | $151k | 21,588 | Dec 18, 2025 |
| Dec 16, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -9,365 | $44.62 | $418k | 15,761 | Dec 18, 2025 |
| Dec 16, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | SOpen-market sale Common Stock10b5-1 | -8,305 | $44.68 | $371k | 13,283 | Dec 18, 2025 |
| Dec 16, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock10b5-1 | -6,360 | $45.21 | $288k | 9,401 | Dec 18, 2025 |
| Dec 16, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | SOpen-market sale Common Stock10b5-1 | -4,195 | $45.24 | $190k | 9,088 | Dec 18, 2025 |
| Dec 16, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 70,600 | Dec 18, 2025 |
| Dec 17, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock10b5-1 | +10,000 | $14.02 | $140k | 19,088 | Dec 18, 2025 |
| Dec 17, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | SOpen-market sale Common Stock10b5-1 | -10,000 | $46.00 | $460k | 9,088 | Dec 18, 2025 |
| Dec 18, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | SOpen-market sale Common Stock10b5-1 | -141 | $46.99 | $6,626 | 8,947 | Dec 18, 2025 |
| Dec 16, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 63,000 | Dec 18, 2025 |
| Dec 16, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 0 | Dec 18, 2025 |
| Dec 17, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 53,000 | Dec 18, 2025 |
| Sep 30, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock10b5-1 | +5,000 | $14.02 | $70k | 17,328 | Oct 1, 2025 |
| Sep 30, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | SOpen-market sale Common Stock10b5-1 | -8,240 | $29.00 | $239k | 9,088 | Oct 1, 2025 |
| Sep 30, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 68,000 | Oct 1, 2025 |
| Sep 15, 2025 | John A Orwin director | MOption exercise Common Stock | +1,300 | $0.00 | $0 | 10,665 | Sep 17, 2025 |
| Sep 15, 2025 | John A Orwin director | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 1,300 | Sep 17, 2025 |
| Aug 8, 2025 | Hollings Renton director | MOption exercise Common Stock10b5-1 | +10,231 | $6.93 | $71k | 15,196 | Aug 12, 2025 |
| Aug 8, 2025 | Hollings Renton director | SOpen-market sale Common Stock10b5-1 | -3,110 | $19.44 | $60k | 12,086 | Aug 12, 2025 |
| Aug 8, 2025 | Hollings Renton director | SOpen-market sale Common Stock10b5-1 | -7,121 | $19.70 | $140k | 4,965 | Aug 12, 2025 |
| Aug 8, 2025 | Hollings Renton director | MOption exercise Common Stockderivative10b5-1 | -10,231 | $0.00 | $0 | 0 | Aug 12, 2025 |
| Jul 2, 2025 | Hollings Renton director | MOption exercise Common Stock10b5-1 | +20,925 | $6.93 | $145k | 25,890 | Jul 3, 2025 |
| Jul 2, 2025 | Hollings Renton director | SOpen-market sale Common Stock10b5-1 | -7,250 | $23.09 | $167k | 18,640 | Jul 3, 2025 |
| Jul 2, 2025 | Hollings Renton director | SOpen-market sale Common Stock10b5-1 | -13,675 | $23.82 | $326k | 4,965 | Jul 3, 2025 |
| Jul 2, 2025 | Hollings Renton director | MOption exercise Common Stockderivative10b5-1 | -20,925 | $0.00 | $0 | 0 | Jul 3, 2025 |
| Jun 18, 2025 | Hollings Renton director | SOpen-market sale Common Stock10b5-1 | -3,015 | $23.97 | $72k | 4,965 | Jun 20, 2025 |
| Jun 18, 2025 | Dennis M Fenton director | SOpen-market sale Common Stock10b5-1 | -3,015 | $23.97 | $72k | 4,965 | Jun 20, 2025 |
| Jun 15, 2025 | Hollings Renton director | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 7,980 | Jun 17, 2025 |
| Jun 15, 2025 | J. Anthony Ware director | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 13,530 | Jun 17, 2025 |
| Jun 15, 2025 | John P. Schmid director | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 52,267 | Jun 17, 2025 |
| Jun 15, 2025 | John A Orwin director | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 9,365 | Jun 17, 2025 |
| Jun 15, 2025 | Magda Marquet director | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 9,930 | Jun 17, 2025 |
| Jun 15, 2025 | Dennis M Fenton director | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 7,980 | Jun 17, 2025 |
| Jun 15, 2025 | Rita Jain director | MOption exercise Common Stock | +7,330 | $0.00 | $0 | 11,864 | Jun 17, 2025 |
| Jun 15, 2025 | J. Anthony Ware director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 15, 2025 | Hollings Renton director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 15, 2025 | John A Orwin director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 15, 2025 | Magda Marquet director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 15, 2025 | Dennis M Fenton director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 15, 2025 | Rita Jain director | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 1,300 | Jun 17, 2025 |
| Jun 15, 2025 | John P. Schmid director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Jun 15, 2025 | Rita Jain director | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| Mar 25, 2025 | John P. Schmid director | JOther Common Stockindirect: By ESOP | +11,068 | $18.18 | $201k | 11,068 | Mar 27, 2025 |
| Jan 13, 2025 | John P. Schmid director | MOption exercise Common Stock | +21,692 | $4.55 | $99k | 25,592 | Jan 15, 2025 |
| Jan 13, 2025 | John P. Schmid director | MOption exercise Common Stock | +20,645 | $8.54 | $176k | 46,237 | Jan 15, 2025 |
| Jan 13, 2025 | John P. Schmid director | MOption exercise Stock Option (right to buy)derivative | -21,692 | $0.00 | $0 | 0 | Jan 15, 2025 |
| Jan 13, 2025 | John P. Schmid director | MOption exercise Stock Option (right to buy)derivative | -20,645 | $0.00 | $0 | 0 | Jan 15, 2025 |
| Jan 7, 2025 | J. Anthony Ware director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | John P. Schmid director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | Hollings Renton director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | John A Orwin director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | Magda Marquet director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | Rita Jain director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 3, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock | +7,288 | - | - | 10,669 | Jan 7, 2025 |
| Jan 3, 2025 | Daniel Faga President, CEO | MOption exercise Common Stock | +34,678 | - | - | 438,036 | Jan 7, 2025 |
| Jan 7, 2025 | Dennis M Fenton director | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 3, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +8,293 | - | - | 14,018 | Jan 7, 2025 |
| Jan 3, 2025 | Paul F. Lizzul Chief Medical Officer | MOption exercise Common Stock | +10,555 | - | - | 26,095 | Jan 7, 2025 |
| Jan 7, 2025 | J. Anthony Ware director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 7, 2025 | John P. Schmid director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 7, 2025 | Hollings Renton director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 7, 2025 | John A Orwin director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 3, 2025 | Daniel Faga President, CEO | FTax withholding Common Stock | -13,033 | $14.60 | $190k | 425,003 | Jan 7, 2025 |
| Jan 7, 2025 | Magda Marquet director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 7, 2025 | Rita Jain director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 7, 2025 | Dennis M Fenton director | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
| Jan 3, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | FTax withholding Common Stock | -2,994 | $14.60 | $44k | 7,675 | Jan 7, 2025 |
| Jan 3, 2025 | Paul F. Lizzul Chief Medical Officer | FTax withholding Common Stock | -4,336 | $14.60 | $63k | 21,759 | Jan 7, 2025 |
| Jan 3, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -3,407 | $14.60 | $50k | 10,611 | Jan 7, 2025 |
| Jan 6, 2025 | Daniel Faga President, CEO | MOption exercise Common Stock | +17,850 | - | - | 442,853 | Jan 7, 2025 |
| Jan 6, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Common Stock | +5,545 | - | - | 13,220 | Jan 7, 2025 |
| Jan 6, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +5,245 | - | - | 15,856 | Jan 7, 2025 |
| Jan 6, 2025 | Paul F. Lizzul Chief Medical Officer | MOption exercise Common Stock | +6,145 | - | - | 27,904 | Jan 7, 2025 |
| Jan 6, 2025 | Daniel Faga President, CEO | FTax withholding Common Stock | -6,387 | $15.30 | $98k | 436,466 | Jan 7, 2025 |
| Jan 6, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | FTax withholding Common Stock | -2,217 | $15.30 | $34k | 11,003 | Jan 7, 2025 |
| Jan 6, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -2,054 | $15.30 | $31k | 13,802 | Jan 7, 2025 |
| Jan 6, 2025 | Paul F. Lizzul Chief Medical Officer | FTax withholding Common Stock | -2,261 | $15.30 | $35k | 25,643 | Jan 7, 2025 |
| Jan 3, 2025 | Paul F. Lizzul Chief Medical Officer | MOption exercise Restricted Stock Unitderivative | -10,555 | $0.00 | $0 | 31,665 | Jan 7, 2025 |
| Jan 3, 2025 | Dennis Mulroy CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitderivative | -8,293 | $0.00 | $0 | 24,877 | Jan 7, 2025 |
| Jan 3, 2025 | Eric J Loumeau CHIEF LEGAL OFFICER | MOption exercise Restricted Stock Unitderivative | -7,288 | $0.00 | $0 | 21,862 | Jan 7, 2025 |
| Jan 3, 2025 | Daniel Faga President, CEO | MOption exercise Restricted Stock Unitderivative | -34,678 | $0.00 | $0 | 104,032 | Jan 7, 2025 |
| Jan 6, 2025 | Daniel Faga President, CEO | MOption exercise Restricted Stock Unitderivative | -17,850 | $0.00 | $0 | 35,700 | Jan 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- EcoR1 Capital, LLCowner, director
- Dennis M Fentondirector
- Daniel FagaPresident, CEO
- Rita Jaindirector
- Eric J LoumeauCHIEF LEGAL OFFICER
- Paul F. LizzulChief Medical Officer
- Dennis MulroyCHIEF FINANCIAL OFFICER
- Magda Marquetdirector
- John A Orwindirector
- Hollings Rentondirector
- John P. Schmiddirector, other
- J. Anthony Waredirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.